Dr. Bateman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1001 Sam Perry Blvd
Fredericksburg, VA 22401
Summary
- Dr. Henry Bateman is a pathologist in Fredericksburg, VA and is affiliated with Mary Washington Hospital. He received his medical degree (MD/PhD) from University of South Carolina School of Medicine and completed residency training at Virginia Commonwealth University in pathology (AP/CP). He completed a fellowship in hematopathology at University of Virginia Medical Center. He is experienced in hematopathology, immunohistochemistry, flow cytometry, health technology/informatics, lymphoma, leukemia, cytopathology, surgical pathology and forensic / autopsy pathology.
Education & Training
- University of Virginia Medical CenterFellowship, Hematopathology, 2019 - 2020
- Virginia Commonwealth University Health SystemResidency, Pathology-Anatomic and Clinical, 2015 - 2019
- University of South Carolina School of MedicineClass of 2015, MD, PhD, Cum Laude
- Virginia Commonwealth University MS, Biomedical Engineering, 2000 - 2003
- Virginia TechBS, Biology, Chemistry, Summa Cum Laude, 1996 - 2000
Certifications & Licensure
- VA State Medical License Active through 2026
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 127 citationsFullerene nanomaterials inhibit the allergic responseJohn J. Ryan, Henry R. Bateman, Alex Stover, Greg Gomez, Sarah K. Norton
Journal of Immunology. 2007-07-01 - 7 citationsTissue distribution of molidone in a multidrug overdose.Dwight D. Flammia, Henry R. Bateman, Joseph J. Saady, Erik D. Christensen
Journal of Analytical Toxicology. 2004-09-01 - 20 citationsSparstolonin B inhibits pro-angiogenic functions and blocks cell cycle progression in endothelial cells.Henry Rhodes Bateman, Qiaoli Liang, Daping Fan, Vanessa Rodriguez, Susan M. Lessner
Plos One. 2013-08-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: